The Patent Finder

Woodward Specialty LLC

Also on record
Records under this name other than the patents Woodward Specialty LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 22 patents it holds.

Back to Woodward Specialty LLC

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,889,685Method for Treating a Sleep Diorder with Eszopiclone Maleate
Grace period ended
 · Low confidence
Grace period endedLow confidence
US 8,877,755Dopamine-Agonist Combination Therapy For Improving Sleep Quality
Grace period ended
 · Low confidence
Grace period endedLow confidence
US 7,465,729Methods of Treatment of Menopause and Perimenopause Using Eszopiclone
Term ended
Term ended Apr 27, 2026 · High confidence
Term endedTerm ended Apr 27, 2026High confidence
US 11,278,492Intranasal Delivery of Olanzapine by Precision Olfactory Device
Lapsed on the fee record
Ended Mar 22, 2026 · High confidence
Lapsed on the fee recordEnded Mar 22, 2026High confidence
US 8,497,268Method for Providing Blook Levels of Eszopiclone with Maleate Salts
Lapsed on the fee record
Ended Jul 30, 2025 · High confidence
Lapsed on the fee recordEnded Jul 30, 2025High confidence
US 7,776,858Methods of Treatment of Chronic Pain Using Eszopiclone
Term ended
Term ended Apr 5, 2025 · High confidence
Term endedTerm ended Apr 5, 2025High confidence
US 7,893,100Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment
Term ended
Term ended Dec 30, 2024 · USPTO record
Term endedTerm ended Dec 30, 2024USPTO record
US 8,329,950Process for Preparation of Trans 4-(3,4-Dichlorophenyl)-1,2,3,4-Tetrahydro-1NAPTHALENAMINE
Lapsed on the fee record
Ended Dec 11, 2024 · Medium confidence
Lapsed on the fee recordEnded Dec 11, 2024Medium confidence
US 8,268,832Maleate Salts of 6-(5-Chloro-2-pyridyl)-5-[(4-methyl-1-piperazinyl)carbonyloxy]-7-oxo-6,7-dihydro-5H-pyrrolo[3,4-b]pyrazine
Lapsed on the fee record
Ended Sep 18, 2024 · Medium confidence
Lapsed on the fee recordEnded Sep 18, 2024Medium confidence
US 7,189,715Compositions comprising zopiclone derivatives and methods of making and using the same
Term ended
Term ended Sep 8, 2024 · USPTO record
Term endedTerm ended Sep 8, 2024USPTO record
10 of 19 patents shown.
Pro members see all 19.
Pro members: see all 19 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited